Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study
Open Access
- 1 December 2017
- journal article
- case report
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 56 (6) , 863-866
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trialThe Lancet, 2015
- Presentation and management of osteoporosis presenting in association with pregnancy or lactationOsteoporosis International, 2015
- Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density—The CONFORS StudyJournal of Bone and Mineral Research, 2014
- Reproductive toxicity of denosumab in cynomolgus monkeysReproductive Toxicology, 2013
- RANKL-RANK interaction in immune regulatory systemsWorld Journal of Orthopedics, 2012
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extensionJournal of Bone and Mineral Research, 2011
- Management of osteoporosis in a pre-menopausal womanBest Practice & Research Clinical Rheumatology, 2010
- Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?Autoimmunity Reviews, 2010
- Prolonged Bisphosphonate Release after Treatment in ChildrenNew England Journal of Medicine, 2007
- Bisphosphonates in pregnancy and lactation-associated osteoporosisOsteoporosis International, 2006